Explore more publications!
Everything Worth Reading
Got News to Share?

Press Releases

BioAge Announces Additional Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor, Demonstrating Potential for Best-in-Class hsCRP Reduction in Participants with Elevated Cardiovascular Risk
January 12, 2026

BioAge Announces Additional Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor, Demonstrating Potential for Best-in-Class hsCRP Reduction in Participants with Elevated Cardiovascular Risk

Indeterminate GlobeNewswire, Inc.
New Data Underscoring Ability of Leapfrog Bio’s OncoSLX Platform to Identify Drug Retargeting Opportunities for Treating Cancer Published in Nature Portfolio Journal
January 12, 2026

New Data Underscoring Ability of Leapfrog Bio’s OncoSLX Platform to Identify Drug Retargeting Opportunities for Treating Cancer Published in Nature Portfolio Journal

Indeterminate GlobeNewswire, Inc.
Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader-Based Medicines in Cancer and Autoimmune Diseases
January 12, 2026

Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader-Based Medicines in Cancer and Autoimmune Diseases

Indeterminate GlobeNewswire, Inc.
Good Clashes With Evil In A Thrilling New Superhero Fiction Novel From Debut Author Ricky Burleson
January 9, 2026

Good Clashes With Evil In A Thrilling New Superhero Fiction Novel From Debut Author Ricky Burleson

Indeterminate GlobeNewswire, Inc.
Lexicon Pharmaceuticals Publishes “Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain” 
January 9, 2026

Lexicon Pharmaceuticals Publishes “Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain” 

Indeterminate GlobeNewswire, Inc.
Memo Therapeutics AG Publishes BKPyV Infection Disease Burden Study in the Journal of Patient-Reported Outcomes
January 9, 2026

Memo Therapeutics AG Publishes BKPyV Infection Disease Burden Study in the Journal of Patient-Reported Outcomes

Indeterminate GlobeNewswire, Inc.
Transgene Publishes Phase I Data Supporting TG4050’s Potential in Preventing Head and Neck Cancer Relapse
January 9, 2026

Transgene Publishes Phase I Data Supporting TG4050’s Potential in Preventing Head and Neck Cancer Relapse

Indeterminate GlobeNewswire, Inc.
Mosaic Digest Celebrates Diverse Literary Voices Featuring Bestselling Authors L.E. Summers and Alexis Anicque
January 8, 2026

Mosaic Digest Celebrates Diverse Literary Voices Featuring Bestselling Authors L.E. Summers and Alexis Anicque

Neutral EIN Presswire
Author Trisha McAfee Releases New Psychological Thriller Tappan Lake: Beneath the Surface
January 6, 2026

Author Trisha McAfee Releases New Psychological Thriller Tappan Lake: Beneath the Surface

Neutral EIN Presswire
Author Viktor Ujkic Releases a Debut Novel ‘Justice Died at Dawn’ Set in a Broken Justice System
January 6, 2026

Author Viktor Ujkic Releases a Debut Novel ‘Justice Died at Dawn’ Set in a Broken Justice System

Neutral EIN Presswire
Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay
January 8, 2026

Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay

Indeterminate GlobeNewswire, Inc.
Plus Therapeutics Announces Read Out of Type B Meeting with the FDA with Goal of Accelerating Approval of REYOBIQ™ for Leptomeningeal Metastases
January 8, 2026

Plus Therapeutics Announces Read Out of Type B Meeting with the FDA with Goal of Accelerating Approval of REYOBIQ™ for Leptomeningeal Metastases

Indeterminate GlobeNewswire, Inc.
VarmX and Rentschler Biopharma partner to advance novel coagulation therapy toward Phase 3 and commercialization
January 8, 2026

VarmX and Rentschler Biopharma partner to advance novel coagulation therapy toward Phase 3 and commercialization

Indeterminate GlobeNewswire, Inc.
Award-Winning Novel Out of Time by M. Jacqueline Murray Redefines Love, Destiny, and the Possibilities of Second Chances
January 8, 2026

Award-Winning Novel Out of Time by M. Jacqueline Murray Redefines Love, Destiny, and the Possibilities of Second Chances

Neutral EIN Presswire
Metabo Drops 2026: Is It Legit? Ingredients, Safety Facts, and Consumer Analysis
January 13, 2026

Metabo Drops 2026: Is It Legit? Ingredients, Safety Facts, and Consumer Analysis

Indeterminate GlobeNewswire, Inc.
Toronto Star Short Story contest opens tomorrow for aspiring writers
January 2, 2026

Toronto Star Short Story contest opens tomorrow for aspiring writers

Indeterminate GlobeNewswire, Inc.
New Book 'Flashpoint Protocol' by C.J. Heston Unveils an AI-Driven Conspiracy in a Gritty, Fast-Paced Techno-Thriller
January 7, 2026

New Book 'Flashpoint Protocol' by C.J. Heston Unveils an AI-Driven Conspiracy in a Gritty, Fast-Paced Techno-Thriller

Neutral EIN Presswire
Unlock the Power of Deliberate Living With New Self-Help & Personal Success Nonfiction Release
January 12, 2026

Unlock the Power of Deliberate Living With New Self-Help & Personal Success Nonfiction Release

Indeterminate GlobeNewswire, Inc.
IRONWAKE Expands the Phoenix Knight Saga as New Reviews Land and Book Two Moves Into Development
January 7, 2026

IRONWAKE Expands the Phoenix Knight Saga as New Reviews Land and Book Two Moves Into Development

Neutral EIN Presswire
Dr. Lauree Brown Announces 'Beyond the Well,' a Historical Novel Reimagining the Life of the Samaritan Woman
January 7, 2026

Dr. Lauree Brown Announces 'Beyond the Well,' a Historical Novel Reimagining the Life of the Samaritan Woman

Neutral EIN Presswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions